BAGNASCO, MARCELLO
 Distribuzione geografica
Continente #
EU - Europa 15.887
AS - Asia 66
SA - Sud America 26
NA - Nord America 1
Totale 15.980
Nazione #
IT - Italia 15.886
CN - Cina 37
BR - Brasile 23
VN - Vietnam 19
SG - Singapore 7
EC - Ecuador 2
ID - Indonesia 2
AM - Armenia 1
AR - Argentina 1
MX - Messico 1
RU - Federazione Russa 1
Totale 15.980
Città #
Genova 10.505
Genoa 3.091
Rapallo 1.354
Vado Ligure 913
Bordighera 23
Beijing 18
Hanoi 8
Ho Chi Minh City 5
Hải Dương 2
Belém 1
Berazategui 1
Campinas 1
Campos dos Goytacazes 1
Canapi 1
Cruz Alta 1
Cupira 1
Feira de Santana 1
Guayaquil 1
Horizontina 1
Ixtapaluca 1
Jatai 1
Juiz de Fora 1
Loja 1
Londrina 1
Macaparana 1
Manado 1
Matinhos 1
Mauá 1
Ninh Bình 1
Olímpia 1
Promissão 1
Querência 1
Ribeirão Preto 1
Rostov-on-Don 1
Santo André 1
Singapore 1
São José do Rio Pardo 1
São Simão 1
Thái Bình 1
Thái Nguyên 1
Tobias Barreto 1
Viamão 1
Yerevan 1
Yogyakarta 1
Totale 15.954
Nome #
Long-term outcome after radioiodine therapy with adjuvant rhTSH treatment: comparison between patients with non-toxic and pre-toxic large multinodular goitre. 203
T cell nature of some lymphokine-activated killer (LAK) cells. Frequency analysis of LAK precursors within human T cell populations and clonal analysis of LAK effector cells. 193
Cetirizine reduces inflammatory cell recruitment and ICAM-1 (or CD54) expression on conjunctival epithelium in both early and late phase reactions after allergen-specific challenge. 192
A study of the efficacy of radioiodine therapy with individualized dosimetry in Graves' disease: need to retarget the radiation committed dose to the thyroid. 179
Adhesion molecules in allergy. 178
Analytical and diagnostic accuracy of "second generation" assays for thyrotrophin receptor antibodies with radioactive and chemiluminescent tracers. 177
Autoantibody profiling of patients with autoimmune thyroid disease using a new multiplexed immunoassay method. 175
T cell activation through different membrane structures (T3/Ti, T11, T44) and frequency analysis of proliferating and interleukin-2 producer T lymphocyte precursors in aged individuals. 165
Abnormal bone scintigraphy and acute-onset severe primary hyperparathyroidism. 161
Soluble CTLA-4 in autoimmune thyroid diseases: Relationship with clinical status and possible role in the immune response dysregulation 159
B7.1 costimulatory molecule is expressed on thyroid follicular cells in Hashimoto's thyroiditis, but not in Graves' disease. 157
Absorption and distribution kinetics of the major Parietaria judaica allergen (Par j 1) administered by noninjectable routes in healthy human beings. 156
Inhibition of adhesion molecules by budesonide on a human epithelial cell line (lung carcinoma) 154
Fibrous invasive (Riedel's) thyroiditis with critical response to steroid treatment. 152
A functional soluble form of CTLA-4 is present in the serum of celiac patients and correlates with mucosal injury 150
T cell activation surface markers and autologous mixed lymphocyte reaction do not differ in true and pseudo food allergy. 150
CD277 an Immune Regulator of T Cell Function and Tumor Cell Recognition 149
Diagnostic accuracy of IgA anti-tissue transglutaminase antibody assays in celiac disease patients with selective IgA deficiency. 145
Clinical efficacy of radioiodine therapy in multinodular toxic goiter, applying an implemented dose calculation algorithm. 144
Unexpected elevated free thyroid hormones in pregnancy 144
Therapeutic Strategies and Clinical Outcome in Papillary Thyroid Microcarcinoma: A Multicenter Observational Study. 142
Allergic subjects express intercellular adhesion molecule-1 (ICAM-1 or CD54) on epithelial cells of conjunctiva allergen challenge. 141
Urticaria and Thyroid Autoimmunity 140
Relationship between circulating anti-thyroglobulin antibodies (TgAb) and tumor metabolism in patients with differentiated thyroid cancer (DTC): prognostic implications 140
Serum cytotoxic T lymphocyte-associated antigen 4 in hymenoptera venom allergy and its modulation by specific immunotherapy 137
The management of the patient with unexpected autoantibody positivity 136
Intercellular adhesion molecule-1 (ICAM-1) and granulocyte-macrophage colony stimulating factor (GM-CSF) co-expression in cutaneous malignant melanoma lesions. 136
TSH receptor autoantibody immunoassay in patients with Graves' disease: Improvement of diagnostic accuracy over different generations of methods. Systematic review and meta-analysis 135
Preliminary evidence for 'aberrant' expression of the leukocyte integrin LFA-1 (CD11a/CD18) on conjunctival epithelial cells of patients with mite allergy 135
Ultrasonography thyroid volume estimation in hyperthyroid patients treated with individual radioiodine dose. 134
Allergen-specific nasal challenge: response kinetics of clinical and inflammatory events to rechallenge. 134
Association of hyperfunctioning thyroid adenoma with thyroid cancer presenting as "trapping only" nodule at (Tc04-)-Tc99m scintigraphy 133
BT3 molecules ligation enhance the proinflammatory responses of human monocytes and monocyte-derived dendritic cells. 133
Effects of conjunctival hyperosmolar challenge in allergic subjects and normal controls. 133
Ligation of the BT3 molecules, members of the B7 family, enhance the proinflammatory responses of human monocytes and monocyte-derived dendritic cells. 133
Autologous mixed lymphocyte reaction in Graves' disease: relationship to clinical status. 132
Thyrotropin receptor autoantibody measurement following radiometabolic treatment of hyperthyroidism: comparison between different methods. 129
Long-term outcome of low-activity radioiodine administration preceded by adjuvant recombinant human TSH pretreatment in elderly subjects with multinodular goiter. 128
THE SOLUBLE FORM OF CTLA-4 FROM SERUM OF PATIENTS WITH AUTOIMMUNE DISEASES REGULATES T-CELL RESPONSES. 128
The adhesion molecules of allergic inflammation: recent insights into their functional roles. 127
Topical ocular levocabastine reduces ICAM-1 expression on epithelial cells both in vivo and in vitro 127
Adhesion molecules: a review of their clinical roles in allergic inflammation 127
Effects of different up-dosing regimens for hymenoptera venom immunotherapy on serum ctla-4 and IL-10. 126
Cetirizine treatment of rhinitis in children with pollen allergy: evidence of its antiallergic activity. 125
Insulin binding on MOLT 4 cells: effect of a sulfonylurea. 124
Why thyroid is major site of thyroid autoantibody synthesis in autoimmune thyroid disease. 124
Seasonal rhinitis and azelastine: long- or short-term treatment? 123
Intercellular adhesion molecule-1 on cultured human epithelial cell lines: influence of proinflammatory cytokines 123
Deflazacort protects against late-phase but not early-phase reactions induced by the allergen-specific conjunctival provocation test. 123
Allergen biodistribution in humans 123
A soluble form of CTLA-4 is present in serum of paediatric patients with acute lymphoblastic leukaemia. 122
Local immunotherapy: pharmacokinetics and efficacy. 122
Co-stimulatory molecules in Graves' disease 122
Prevalence of post-partum thyroiditis in Liguria (Italy): an observational study. 122
Circulating T lymphocytes in Hashimoto's disease: imbalance of subsets and presence of activated cells. 122
SERUM LAIR-2 IS INCREASED IN AUTOIMMUNE THYROID DISEASES 121
Expression of intercellular adhesion molecule-1 (ICAM-1) on thyroid epithelial cells in Hashimoto's thyroiditis but not in Graves' disease or papillary thyroid cancer. 120
Occurrence of lymphocyte proliferative response to thyroglobulin and antithyroglobulin antibodies in normal individuals: lack of correlation with HLA. 120
The effect of methimazole on the immune system is unlikely to operate directly on T lymphocytes. 119
Activation of T lymphocytes and autologous mixed lymphocyte reaction in allergic patients. 119
Proliferation of T8-positive cytolytic T lymphocytes in response to thyroglobulin in human autoimmune thyroiditis: analysis of cell interactions and culture requirements. 117
In situ hybridization analysis of ICAM-1 (CD54) mRNA on conjunctival epithelium during allergic inflammation 116
Oversecretion of soluble CTLA-4 in various autoimmune diseases overlapping celiac disease. 116
High levels of soluble ctla-4 are present in anti-mitochondrial antibody positive, but not in antibody negative patients with primary biliary cirrhosis. 116
Azelastine eye drops reduce and prevent allergic conjunctival reaction and exert anti-allergic activity. 116
Differential regulation of Fas-mediated apoptosis in both thyrocyte and lymphocyte cellular compartments correlates with opposite phenotypic manifestations of autoimmune thyroid disease 116
Occurrence of overt celiac disease in the elderly following total thyroidectomy 115
Autoimmune thyroid disease: purification and phenotypic analysis of intrathyroid T cells. 115
Incidence of T cell subset imbalance in relatives of Graves' disease patients. 115
Allergen specific challenge induces intracellular adhesion molecul-1 (ICAM-1 or CD54) on nasal epithelial cells in allergic subjects. 114
Intraepithelial gamma/delta T-cells and intestinal villous atrophy. 114
Population screening for coeliac disease in a low prevalence area in Italy 114
A multicenter study for the evaluation of the reference interval for TSH in Italy (ELAS TSH Italian Study) 112
Comparison of ELISA for tissue transglutaminase autoantibodies with antiendomysium antibodies in pediatric and adult patients with celiac disease 111
Effect of tetroxoprim and sulfadiazine on T-lymphocyte proliferation and gamma-interferon production 111
Oral cromolyn in food allergy: in vivo and in vitro effects. 111
Expression of very late activation antigen-1 on intrathyroid lymphocytes in autoimmune thyroid disease. 111
T-lymphocyte activation and allergy. 111
Influence of H1-receptor antagonists on adhesion molecules and cellular traffic. 110
Circulating T-cell subsets in Graves' disease: differences between patients with active disease and in remission after 131I-therapy. 110
Human T-lymphocyte subpopulations in Hashimoto's disease. 110
Immunoassay of thyroid peroxidase autoantibodies: diagnostic performance in automated third generation methods. A multicentre evaluation. 109
Stress and autoimmune thyroid diseases 108
The soluble CTLA-4 receptor and its role in autoimmune diseases: an update 108
Atopic asthma: evaluation of T-cell activation by means of 4F2 monoclonal antibody 108
Differentiated thyroid cancer incidentally detected by 18F-FDG PET/CT: Patient's future in a hot-spot? 108
null 106
Pharmacokinetics of an allergen and a monomeric allergoid for oromucosal immunotherapy in allergic volunteers. 106
Retrospective analysis of the association of nodular goiter with primary and secondary hyperparathyroidism. 106
A functional soluble form of CTLA-4 is present in the serum of celiac patients and correlates with mucosal injury and tissue-transglutaminase antibody production. 106
Pharmacokinetics of radiolabelled Par j 1 administered intranasally to allergic and healthy subjects 106
Phenotypic and functional analysis at the clonal level of infiltrating T lymphocytes in papillary carcinoma of the thyroid: prevalence of cytolytic T cells with natural killer-like or lymphokine-activated killer activity. 103
Costimulatory molecules and autoimmune thyroid diseases 103
Sublingual swallow or spit? 102
Follicular thyroid cells of autoimmune thyroiditis may coexpress [CAM1 (CD54) and its natural ligand LFA1 (CDlla/CD18) 101
«ICAM-1 on epithelial cells in allergic subjects: a hallmark of allergic inflammation» 101
Quantitative determination of Fibronectin (FN): evaluation of immunoturbidimetric and rate nephelometric techniques for FN assay in the different biologic materials. 101
ALTERAZIONI FENOTIPICHE E FUNZIONALI DI LINFOCITI T NEL M. DI BASEDOW TRATTATI CHIRURGICAMENTE 100
Protective effects of deflazacort on allergen-specific conjunctival challenge. 99
Circulating T cell subsets in euthyroid Graves' disease. 97
Totale 12.782
Categoria #
all - tutte 47.695
article - articoli 44.888
book - libri 0
conference - conferenze 1.142
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.665
Totale 95.390


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021491 0 0 0 0 43 57 32 84 84 90 47 54
2021/20221.723 32 130 113 227 81 124 131 361 71 155 74 224
2022/20231.614 159 106 21 178 271 329 5 119 282 12 121 11
2023/2024697 36 113 12 83 68 120 31 40 44 8 42 100
2024/20252.113 30 170 127 141 274 241 216 305 72 104 176 257
2025/20261.064 421 97 233 313 0 0 0 0 0 0 0 0
Totale 16.068